Searched for
CNS PHARMACEUTICALS
RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targetsElara has initiated coverage on four pharmaceutical stocks, assigning Buy, Accumulate and Reduce ratings. Alkem Laboratories emerged as its...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- PM Modi to inaugurate Bhogapuram Airport in Andhra on August 1The state government views Bhogapuram Airport not merely as an infrastructure project, but as a transformational asset for the entire North...
- PM Modi to inaugurate Bhogapuram Airport on August 1 in Andhra PradeshPrime Minister Narendra Modi will inaugurate the Alluri Sitarama Raju International Airport on August 1. This new airport is expected to bo...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Risk is integral to the market; but there are different kinds of risk: 6 mid-cap stocks with upside potential of up to 21%We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOil is crucial for every part of the Indian economy: From government to consumer, its price impacts spending by every stakeholder. So, till...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Eris signs definitive pact to buy Strides’ India portfolio for Rs 500 crThe acquisition is Eris’s fourth and the largest buyout in the last 18 months. With this, the company will be among the top ten companies i...
- Strides Shasun gets CCI nod to buy Sun Pharma's two divisionsStrides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.
- TCG ties up with JSW Lifesciences for drug clinical studiesTCG Lifesciences today said it has entered into an agreement with Austria-based JSW Lifesciences for collaboration services in clinical stu...
- Lupin's Japanese arm gets nod for 10 productsLupin's Japanese subsidiary Kyowa Pharma has received approvals for 10 products and expects to launch these in July 2008 post NHI listing.
- Torrent Pharma launches 3 new speciality armsAhmedabad-based Torrent Pharmaceuticals on Friday said it has launched three new speciality divisions to cater to niche therapeutic areas o...
- Suven ties up with US-based pharma coSuven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...
Load More
